411 related articles for article (PubMed ID: 31919501)
21. [Perianal fistulas in Crohn's disease: treatment results at an interdisciplinary unit].
Iesalnieks I; Glass H; Kilger A; Ott C; Klebl F; Agha A; Schlitt HJ; Strauch U
Chirurg; 2009 Jun; 80(6):549-58. PubMed ID: 19387561
[TBL] [Abstract][Full Text] [Related]
22. Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic review.
Panes J; Reinisch W; Rupniewska E; Khan S; Forns J; Khalid JM; Bojic D; Patel H
World J Gastroenterol; 2018 Nov; 24(42):4821-4834. PubMed ID: 30479468
[TBL] [Abstract][Full Text] [Related]
23. Surgical options for perianal fistula in patients with Crohn's disease: A comparison of seton placement, fistulotomy, and stem cell therapy.
Park MY; Yoon YS; Kim HE; Lee JL; Park IJ; Lim SB; Yu CS; Kim JC
Asian J Surg; 2021 Nov; 44(11):1383-1388. PubMed ID: 33966965
[TBL] [Abstract][Full Text] [Related]
24. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
van Rijn KL; Meima-van Praag EM; Bossuyt PM; D'Haens GR; Gecse KB; Horsthuis K; Snijder HJ; Tielbeek JAW; Buskens CJ; Stoker J
J Crohns Colitis; 2022 Jun; 16(5):708-716. PubMed ID: 34644395
[TBL] [Abstract][Full Text] [Related]
25. Lack of anti-TNF drugs levels in fistula tissue - a reason for nonresponse in Crohn's perianal fistulating disease?
Adegbola SO; Sarafian M; Sahnan K; Pechlivanis A; Phillips RKS; Warusavitarne J; Faiz O; Haddow J; Knowles C; Tozer P; Holmes E; Hart A
Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):18-26. PubMed ID: 33522723
[TBL] [Abstract][Full Text] [Related]
26. Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
Chan M; Fung M; Chin Koon Siw K; Khanna R; de Buck van Overstraeten A; Sabri E; McCurdy JD
Inflamm Bowel Dis; 2023 May; 29(5):763-770. PubMed ID: 35815783
[TBL] [Abstract][Full Text] [Related]
27. Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
Le Baut G; Peyrin-Biroulet L; Bouguen G; Gornet JM; Stefanescu C; Amiot A; Laharie D; Altwegg R; Fumery M; Trang C; Vuitton L; Simon M; Gilletta de Saint Joseph C; Nahon S; Caillo L; Del Tedesco E; Plastaras L; Aubourg A; Pineton de Chambrun G; Seksik P; Viennot S
Aliment Pharmacol Ther; 2018 Oct; 48(8):831-838. PubMed ID: 30194687
[TBL] [Abstract][Full Text] [Related]
28. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the Efficacy of the Various Treatment Modalities in the Management of Perianal Crohn's Fistula: A Review.
Feroz SH; Ahmed A; Muralidharan A; Thirunavukarasu P
Cureus; 2020 Dec; 12(12):e11882. PubMed ID: 33415035
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
31. Approach to medical therapy in perianal Crohn's disease.
Vasudevan A; Bruining DH; Loftus EV; Faubion W; Ehman EC; Raffals L
World J Gastroenterol; 2021 Jul; 27(25):3693-3704. PubMed ID: 34321838
[TBL] [Abstract][Full Text] [Related]
32. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?
Rinawi F; Greer MC; Walters T; Church PC; Ricciuto A; Langer JC; Griffiths AM
J Pediatr Surg; 2022 Nov; 57(11):569-574. PubMed ID: 35491271
[TBL] [Abstract][Full Text] [Related]
33. Long-term indwelling seton for complex anal fistulas in Crohn's disease.
Thornton M; Solomon MJ
Dis Colon Rectum; 2005 Mar; 48(3):459-63. PubMed ID: 15719188
[TBL] [Abstract][Full Text] [Related]
34. Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor SJ; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson AJ; Welman CJ; Yong EXZ; De Cruz P; van Langenberg D; Sparrow MP; Ding NS
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1306-1314. PubMed ID: 34389484
[TBL] [Abstract][Full Text] [Related]
35. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
[TBL] [Abstract][Full Text] [Related]
36. [Perianal Crohn's disease].
Burri E; Vavricka SR
Ther Umsch; 2013 Jul; 70(7):417-28. PubMed ID: 23798025
[TBL] [Abstract][Full Text] [Related]
37. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
McCurdy JD; Parlow S; Dawkins Y; Samji K; Rhee GG; Oliveira L; Macdonald B; Sabri E; Murthy S
Dig Dis Sci; 2020 Jun; 65(6):1784-1789. PubMed ID: 31642006
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of fistulizing Crohn's disease].
Tonkić A; Borzan V
Acta Med Croatica; 2013 Apr; 67(2):191-4. PubMed ID: 24471302
[TBL] [Abstract][Full Text] [Related]
39. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review.
Tandon P; Rhee GG; Schwartz D; McCurdy JD
Dig Dis Sci; 2019 Nov; 64(11):3066-3077. PubMed ID: 31030304
[TBL] [Abstract][Full Text] [Related]
40. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS
Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
